Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
AI Generated
May 9, 2026, 22:55

Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library

Transfusion Evidence Library, shared a post on LinkedIn about a recent article by Al-Samkari H et al. published in NEJM, adding:

”New from the Transfusion Evidence Alert:

Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.”

Title: Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia

Authors: Hanny Al-Samkari, César Muñoz, Çağdaş Geredeli, Ioannis Korantzis, Bárbara González Astorga, Can Arslan,  João F. Cordeiro Camargo, Franck Scotté , Gilberto Borges, Kai Wang,  Martin Kuter,  Gerald A. Soff

Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia - Transfusion Evidence Library

Stay updated on all scientific advances with Hemostasis Today.

Bárbara González Astorga Çağdaş Geredeli Can Arslan César Muñoz Franck Scotté Gerald A. Soff Gilberto Borges Hanny Al-Samkari Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Ioannis Korantzis João F. Cordeiro Camargo Kai Wang Martin Kuter Medicine thrombosis Transfusion Evidence Library
NewsFeed